Replicel Life Sciences Inc
XTSX:RP

Watchlist Manager
Replicel Life Sciences Inc Logo
Replicel Life Sciences Inc
XTSX:RP
Watchlist
Price: 0.015 CAD -25%
Market Cap: 954.8k CAD
Have any thoughts about
Replicel Life Sciences Inc?
Write Note

Net Margin
Replicel Life Sciences Inc

-19.6%
Current
-630%
Average
-0.1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-19.6%
=
Net Income
-69.3k
/
Revenue
353.7k

Net Margin Across Competitors

Country CA
Market Cap 921.4k CAD
Net Margin
-20%
Country US
Market Cap 1.3T USD
Net Margin
9%
Country US
Market Cap 207.5B USD
Net Margin
14%
Country US
Market Cap 173.4B USD
Net Margin
18%
Country KR
Market Cap 70.2T KRW
Net Margin
24%
Country CH
Market Cap 40.8B CHF
Net Margin
9%
Country US
Market Cap 39.2B USD
Net Margin
9%
Country US
Market Cap 38.5B USD
Net Margin
22%
Country US
Market Cap 26.5B USD
Net Margin
21%
Country US
Market Cap 23.7B USD
Net Margin
-36%
Country US
Market Cap 23.6B USD
Net Margin
17%

Profitability Report

View the profitability report to see the full profitability analysis for Replicel Life Sciences Inc.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-19.6%
=
Net Income
-69.3k
/
Revenue
353.7k
What is the Net Margin of Replicel Life Sciences Inc?

Based on Replicel Life Sciences Inc's most recent financial statements, the company has Net Margin of -19.6%.